Helping Women with GDM Safely Switch from InnoLet

Helping Women with GDM Safely Switch from InnoLet

Dr Sarah Price

How often should women with Gestational Diabetes be testing?

What if my patient is already using the InnoLet insulin device?

What are the alternative insulins?

Are there any changes to short acting insulins?

Hypoglycaemia in Gestational Diabetes

Working with GPs

Dr Gary Deed

Quality care for people living with Gestational Diabetes

Working with your local maternity service

Emily Fitz

Discontinuation of Protaphane InnoLet insulin device

Education for women who have previously used Protaphane

Downloadable Resources

The ADS gratefully acknowledges the support from Novo Nordisk for these video resources.

Videos will be available soon. Stay tuned!

Helping Women with GDM Safely Switch from InnoLet

Transitioning from InnoLet: What Every Health Professional Needs to Know

The InnoLet® insulin device was discontinued in Australia from February 2025, necessitating continued support from health professionals to ensure a safe, timely, and patient-centred transition to alternative insulin options or delivery systems. We have developed this short, practical video series featuring clinical experts Dr Sarah Price, Dr Gary Deed, and Emily Fitz, as a training resource that provides guidance. Please also note the ADIPS 2025 Consensus Recommendations for the screening and diagnosis of GDM that was published June 2025 in the MJA.
These video resources have been developed in collaboration with ADIPS, ADEA, RACGP, SOMANZ and Diabetes Australia and funded by an unrestricted grant from Novo Nordisk.

Part 1

Ramzi Ajjan

Over-the-Counter Continuous Glucose Monitoring – Data for All or a Disaster Waiting to Happen?

Ramzi Ajjan

If You Had to Pick Just One – GLP-1RA, GIP/GLP-1RA or SGLT2i for Type 2 Diabetes?

Day 4

Day 4 highlights will be available soon. Stay tuned!

TBC


Webinar Search

Webinar Categories

Disclaimer: This webpage including the open access webinars is intended for use by healthcare professionals only. The presentations and its content cannot be reproduced, copied or provided to other third parties. Please contact the Australian Diabetes Society via email admin@diabetessociety.com.au for any enquiries.

ADS Professional Education Webinars

Disclaimer Notice

By agreeing to this disclaimer notice; you acknowledge that you are a registered healthcare professional accessing the open access clinical educational webinars hosted by the Australian Diabetes Society. The presentations and its content cannot be reproduced, copied or provided to other third parties. Please contact the Australian Diabetes Society via email admin@diabetessociety.com.au for any enquiries.